Emergent Large Vessel Occlusion Stroke During New York City's COVID-19 Outbreak: Clinical Characteristics and

Shahram Majidi1, Johanna T Fifi1, Travis R Ladner1

  • 1Department of Neurosurgery (S.M., J.T.F., T.R.L., J.L.-R., K.A.Y., B.Y., N.D., T.J.O., T.S., R.D.L., J.M.), Icahn School of Medicine at Mount Sinai, New York, NY.

Stroke
|August 7, 2020
PubMed

Insights

During the COVID-19 pandemic, over half of emergent large vessel occlusion (ELVO) stroke patients were COVID-19 positive. This study observed a 2-fold increase in ELVO stroke incidence during the pandemic

Area of Science:

  • Neurology
  • Infectious Diseases
  • Public Health

Background:

  • The 2019 novel coronavirus (COVID-19) pandemic has led to increased reports of ischemic stroke, particularly in severe cases.
  • Emergent large vessel occlusion (ELVO) is a severe type of ischemic stroke requiring immediate intervention.

Purpose of the Study:

  • To evaluate the relationship between emergent large vessel occlusion (ELVO) and the coronavirus disease 2019 (COVID-19) outbreak.
  • To compare characteristics of ELVO patients with and without COVID-19 during the pandemic's peak.

Main Methods:

  • A retrospective, observational case series was conducted at Mount Sinai Health System Hospitals in New York City.
  • Data from ELVO patients during the peak 3 weeks of COVID-19 hospitalizations were analyzed, comparing COVID-19 positive and negative cohorts.
  • ELVO stroke incidence was compared to the pre-COVID period.

Main Results:

  • Forty-five ELVO patients were identified; 53% tested positive for COVID-19.
  • COVID-19 positive patients were younger (59 vs 74 years), more likely male (75% vs 43%), and less likely White (8% vs 38%).
  • A 2-fold increase in ELVO incidence was observed during the COVID-19 outbreak compared to a similar pre-COVID period.

Conclusions:

  • Over half of ELVO stroke patients during the NYC COVID-19 peak were COVID-19 positive.
  • COVID-19 positive ELVO patients exhibited distinct demographic characteristics (younger, male, non-White).
  • Findings suggest an increased incidence of ELVO stroke during the COVID-19 pandemic peak.
Abstract

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
114
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
218
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
276
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
154
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
241
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
122